EVALUATION OF ANTIDIABETIC AND ANTIHYPERLIPIDEMIC EFFECT OF VERNONIA DIVERGENS IN STREPTOZOTOCIN-INDUCED DIABETIC RATS
Objective: The current investigation for antidiabetic activity of the plant Vernonia divergens (DC.) Edgew. has not been reported till date. However, to enlighten the folkloric claim of the plant, the study was carried out on various animal models such as albino mice, albino rabbits, Wistar rats, rabbits, hamsters, dogs, and monkeys.
Methods: The whole plant of V. divergens was studied on various animal models. Screening methods generally have been carried out on rodents and non-rodents, respectively. Various biochemical and hematological parameters such as serum glucose, plasma insulin, lipid profile and activities of liver enzymes, red blood cells, white blood cells, hemoglobin, and differential counts were measured to assess the antihyperglycemic and antihyperlipidemic activities as well as safety profile of the extract.
Results: Among all experimental extracts of V. divergens, it was found that the aqueous and methanolic extracts had maximum control of blood glucose in diabetic Wistar rats. While comparing with normoglycemic animals, it was observed that reduction of blood sugar level and increase in plasma insulin level are maximum with test extract. Among the study, the effects of the methanolic extract of V. divergens (MEVD) and aqueous extract of V. divergens (AEVD) were done through oral route in both the models, i.e., normoglycemic and hyperglycemic animal models. The safety profile was evaluated by toxicological evaluation and observed that, even at a higher dose level of 3000 mg/kg body weight, the MEVD and AEVD were safe and retain normal physiological and behavioral effect. The whole protein, whole cholesterol, aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase enzyme activity of streptozotocin-administered rats showed significantly higher than normal rats, and the test extract-treated rats significantly reduced the elevated levels.
Conclusion: It is concluded that the MEVD and AEVD (DC.) Edgew. might be beneficial in effectively reducing the blood glucose concentration and managing the various complications of diabetes. However, in comparison between both the extracts, the methanol extract was found to be significantly more potent than that of the A.E. in all aspects.
2. Cline GW, Petersen KF, Krssak M, Shen J, Hundal RS, Trajanoski Z, et al. Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in Type 2 diabetes. N Engl J Med 1999;341:240-6.
3. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995- 2025: Prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414-31.
4. Boyle JP, Honeycutt AA, Narayan KM, Hoerger TJ, Geiss LS, Chen H, et al. Projection of diabetes burden through 2050: Impact of changing demography and disease prevalence in the U.S. Diabetes Care 2001;24:1936-40.
5. Shukia R, Sharma SB, Puri D, Prabhu KM, Murthy PS. Medicinal plants for treatment of diabetes mellitus. Indian J Clin Biochem 2000;15 Suppl 1:169-77.
6. Odeigah PG, Taiwo IA, Akomolafe EO, Durojaiye DO. Hypoglycaemic actions of medicinal plants with tolbutamide in the albino rat. Diabetes Int 1999;9:71-3.
7. Taiwo IA, Odeigah PG, Ogunkanmi LA. The glycemic effects of Vernonia amygdalina and V. tenoreana with tolbutamide in rats and the implications for the treatment of diabetes mellitus. J Sci Res Dev 2008; 11:122-30.
8. Gyang SS, Nyam DD, Sokomba EN. Hypoglycaemic activity of Vernonia amygdalina (chloroform extract) in normoglycaemic and alloxan-induced hyperglycaemic rats. J Pharm Bioresour 2004;1:61-6.
9. Al-Ahmed FA, Dl-Densary ES, Zaki M, El-Sawaf HA, Abu-Jayyab AR. Ineraction between diazekpamand oral antidiabetic agents on serum glucose. Insulin and chromium levels in rats. Biosci Rep 1989;9:347 50.
10. Dash GK, Suresh P, Ganapati S. Studies on hypoglycaemic and wound healing activities of Lantana camara Linn. J Nat Rem 2001;1:105.
11. Rath D, Panigrahy S, Panigrahi S, Kar D, Maharana L. Antidiabetic effect of extracts of Blumea lacera dc. In streptozotocin induced hyperglycemic rats. Int J Pharm Pharm Sci 2017;9:218-23.
12. Saxena AM, Murthy PS, Mukherjee SK. Mode of action of three structurally different hypoglycemic agents: A comparative study. Indian J Exp Biol 1996;34:351-5.
13. Maharana L, Kar DM, Pattnaik S. Antidiabetic evaluation of aqueous extract of aerial parts of Mollugo pentaphylla L. Int J Pharm Pharm Sci 2012;4:269-75.
14. Ghosh MN, editor. Fundamentals of Experimental Pharmacology. 2nd ed. Calcutta: Scientific Book Agency; 1984.
15. Riley H, Spinks A. Biological assessment of tranquilisers. J Pharmacol 1958;10:657-71.
16. Kuikarni SK. Handbook of Experimental Pharmacology. 2nd ed. New Delhi: Vallabh Prakashan; 1993.
17. Fartyal M. Nerium oleander Linn. In vitro alpha amylase inhibitory potential of stem and root extracts. Int J Curr Pharm Res 2016;9:37-41.
18. Raphael KR, Sabu MC, Kuttan R. Hypoglycemic effect of methanol extract of Phyllanthus amarus Schum and Thonn on alloxan induced diabetes mellitus in rats and its relation with antioxidant potential. Indian J Exp Biol 2002;40:905-9.
19. Ng KW, Salhimi SM, Majid AM, Chan KL. Anti-angiogenic and cytotoxicity studies of some medicinal plants. Planta Med 2010; 76:935 40.
20. Available from: http://www.diabetes India.com.
21. Guyton AC, Hall JE. Text Book of Medical Physiology. 11th ed. Philadelphia, PA: Elsevier; 2005.
22. Akhtr MS, Khan QM, Khaliq T. Effect of Euphorbia prostrata and Fumaria parviflora in normoglycemic and alloxan treated hyperglycaemic rabbits. Planta Med 1984;50:138-42.
23. Davis SN, Granner DK. Insulin, oral hypoglycemic agents and the pharmacology of the endocrine pancreas. In: Goodman Gilman’s the Pharmacological Basis of Therapeutics. 10th ed. USA: The McGraw- Hill Companies Inc.; 2001.
24. Ayinla MT, Dada SO, Shittu ST, Olayaki LA, Akiode AO, Ojulari SL. Anti-hyperlipidemic effect of aqueous leaf extract of Ocimum gratissimum in alloxan induced diabetic rats. Int J Med Med Sci 2011;3:360-3.
25. Soliman AM. Potential impact of Paracentrotus lividus extract on diabetic rat models induced by high fat/streptozotocin. J Basic Appl Zool 2016;77:8-20.
26. Elberry AA, Harraz FM, Ghareib SA, Gabr SA, Nagy AA, Abdel- Sattar E. Methanolic extract of Marrubium vulgare ameloriates hyperglycemia in streptozotocin-induced diabetic rats. Int J Diabetes Mellitus 2015;3:37-44.
27. Abdulazeez MA, Ibrahim K, Bulus K, Babvoshia HB, Abdullahi Y. Effect of combined use of Ocimum gratissimum and Vernonia amygdalina extract on the activity of angiotensin converting enzyme, hypolipidemic and antioxidant parameters in streptozotocin-induced diabetic rats. Afr J Biochem Res 2013;7:165-73.
28. Haardman JG, Limbird LE, Gilman AG. The Pharmacological Basis of Therapeutics. 10th ed. New York: McGraw Hill; 2001.
29. Felig P, Marliss E, Ohman JL, Cahill CF Jr. Plasma amino acid levels in diabetic ketoacidosis. Diabetes 1970;19:727-8.
30. Whitehead MW, Hawkes ND, Hainsworth I, Kingham JG. A prospective study of the causes of notably raised aspartate aminotransferase of liver origin. Gut 1999;45:129-33.
31. Maxwell DB, Fisher EA, Ross-Clunis HA, Estep HL. Serum alkaline phosphatase in diabetes mellitus. J Am Coll Nutr 1986;5:55-9.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.